Symbol="IKNA"
AssetType="Common Stock"
Name="Ikena Oncology Inc"
Description="Ikena Oncology, Inc., a targeted oncology company, is focused on developing new cancer therapies that target key signaling pathways that drive cancer formation and spread. The company is headquartered in Boston, Massachusetts."
CIK="1835579"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="50 NORTHERN AVE., BOSTON, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="177586000"
EBITDA="-68655000"
PERatio="None"
PEGRatio="None"
BookValue="3.724"
DividendPerShare="0"
DividendYield="0"
EPS="-1.8"
RevenuePerShareTTM="0.484"
ProfitMargin="0"
OperatingMarginTTM="-3.958"
ReturnOnAssetsTTM="-0.228"
ReturnOnEquityTTM="-0.403"
RevenueTTM="17547000"
GrossProfitTTM="-48703000"
DilutedEPSTTM="-1.8"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0.57"
AnalystTargetPrice="17.67"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="3.126"
PriceToBookRatio="0.66"
EVToRevenue="0.208"
EVToEBITDA="0.968"
Beta="0.765"
num_52WeekHigh="7.64"
num_52WeekLow="1.94"
num_50DayMovingAverage="6.16"
num_200DayMovingAverage="4.429"
SharesOutstanding="36270000"
DividendDate="None"
ExDividendDate="None"
symbol="IKNA"
open="4.17"
high="4.71"
low="4.17"
price="4.54"
volume="169624.00"
latest_trading_day="2023-08-10"
previous_close="4.20"
change="0.34"
change_percent="8.0952%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="10"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="90"
Volume_recent_avg="102404"
Change_recent_avg="0.01"
Delta_recent_avg="0.52"
Variance_recent_avg="0.26"
Change_ratio_recent_avg="0.2"
RSI_change="FALSE"
ADX_change="FALSE"

event="aroon_milestone_negative_10"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="90"
Aroon_momentum_negative="10"
image_negative_thumbnail_id_1="108"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0068.jpeg"
image_negative_thumbnail_id_2="1132"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0165.jpeg"
image_neutral_thumbnail_id_1="546"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0053.jpeg"
image_neutral_thumbnail_id_2="565"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0034.jpeg"
image_positive_thumbnail_id_1="630"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0078.jpeg"
image_positive_thumbnail_id_2="950"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0112.jpeg"
image_professor_thumbnail_id_1="1173"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0007.jpeg"
image_professor_thumbnail_id_2="1179"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0013.jpeg"
